Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1376339/000137633917000138/mdxg-2017930x10xq.htm
• | Q3 2017 revenue of $84.6 million exceeded MiMedx guidance range of $79 to $80 million |
• | Q3 2017 revenue grew 31% over Q3 2016 revenue |
• | Wound Care revenue of $61.9 million grew 24% over Q3 2016 |
• | Surgical, Sports Medicine and Orthopedics (SSO) revenue of $22.7 million grew 56% over Q3 2016 |
• | 26 of 27 quarters of meeting or exceeding revenue guidance |
• | Distributor and OEM revenue was below 5% |
• | First nine months of 2017 revenue grew 33% over first nine months of 2016 |
• | Days Sales Outstanding (DSO) of 65 days, an improvement of 7 days from prior quarter end |
• | Gross profit margin increased to 89% compared to 88% in Q3 2016 |
• | Operating Income of $8.8 million increased 88% over Q3 2016 |
• | Net income of $17.5 million increased 426% over Q3 2016 |
• | Positive Net Cash Flow from Operations of $18.0 million compared to $2.8 million in Q3 2016 |
• | Returned $29.2 million to MiMedx shareholders through share repurchases in the quarter |
• | 23rd consecutive quarter of positive Adjusted EBITDA* |
• | Adjusted EBITDA* of $15.6 million increased 38% over Q3 2016 |
• | GAAP EPS of $0.15 (diluted) compared to $0.03 (diluted) for Q3 2016 |
• | Adjusted EPS* of $0.08 (diluted) compared to $0.06 (diluted) for Q3 2016 |
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Mimedx Group, Inc..
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1376339/000137633917000138/mdxg-2017930x10xq.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years